Terms: = Lymphoma AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951
83 results:
1. Comparative safety of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced anaplastic lymphoma kinase-mutated non-small cell lung cancer: Systematic review and network meta-analysis.
Luo Y; Zhang Z; Guo X; Tang X; Li S; Gong G; Gao S; Zhang Y; Lin S
Lung Cancer; 2023 Oct; 184():107319. PubMed ID: 37597303
[TBL] [Abstract] [Full Text] [Related]
2. Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials.
Gong IY; Aminilari M; Landego I; Hueniken K; Zhou Q; Kuruvilla J; Hodgson DC
Leuk Lymphoma; 2023 Oct; 64(10):1643-1654. PubMed ID: 37548344
[TBL] [Abstract] [Full Text] [Related]
3. Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World Experience.
Rupp M; Fanton-Aita F; Snow S; Wheatley-Price P; Melosky B; Juergens RA; Chu Q; Blais N; Banerji S; Ng R; Khoudigian S; Sharma A; On PV; Liu G
Curr Oncol; 2023 Jul; 30(7):6559-6574. PubMed ID: 37504341
[TBL] [Abstract] [Full Text] [Related]
4. Involvement of cutavirus in a subset of patients with cutaneous T-cell lymphoma with an unfavorable outcome.
Hashida Y; Nakajima K; Higuchi T; Nakai K; Daibata M
J Clin Virol; 2023 Aug; 165():105523. PubMed ID: 37336173
[TBL] [Abstract] [Full Text] [Related]
5. TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia.
Hara Y; Shiba N; Yoshida K; Yamato G; Kaburagi T; Shiraishi Y; Ohki K; Shiozawa Y; Kawamura M; Kawasaki H; Sotomatsu M; Takizawa T; Matsuo H; Shimada A; Kiyokawa N; Tomizawa D; Taga T; Ito E; Horibe K; Miyano S; Adachi S; Taki T; Ogawa S; Hayashi Y
Genes Chromosomes Cancer; 2023 Jul; 62(7):412-422. PubMed ID: 37102302
[TBL] [Abstract] [Full Text] [Related]
6. [Prognostic analysis of children with Philadelphia chromosome-like acute lymphoblastic leukemia common genes].
Hu WD; Li B; Su SF; Liu YF; Liu W; Zhang WL; Zuo WL; Yu RH
Zhonghua Er Ke Za Zhi; 2023 May; 61(5):446-452. PubMed ID: 37096265
[No Abstract] [Full Text] [Related]
7. Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia.
Tan Y; Shan L; Zhao L; Deng B; Ling Z; Zhang Y; Peng S; Xu J; Duan J; Wang Z; Yu X; Zheng Q; Xu X; Tian Z; Zhang Y; Zhang J; Chang AH; Feng X; Pan J
J Hematol Oncol; 2023 Apr; 16(1):34. PubMed ID: 37020231
[TBL] [Abstract] [Full Text] [Related]
8. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy.
Wang XS; Srour SA; Mendoza T; Whisenant M; Subbiah I; Gonzalez E; Kamal M; Shen SE; Cleeland C; Kebriaei P; Rezvani K; Neelapu S; Ahmed S; Shpall E
Br J Haematol; 2023 May; 201(4):738-746. PubMed ID: 36733986
[TBL] [Abstract] [Full Text] [Related]
10. Familial risk associated with lung cancer as a second primary malignancy in first-degree relatives.
Ji J; Sundquist J; Sundquist K; Zheng G
BMC Cancer; 2022 Oct; 22(1):1057. PubMed ID: 36224547
[TBL] [Abstract] [Full Text] [Related]
11. Chimeric antigen receptor T-cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis.
Shargian L; Raanani P; Yeshurun M; Gafter-Gvili A; Gurion R
Br J Haematol; 2022 Sep; 198(5):838-846. PubMed ID: 35765220
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype.
Marcault C; Boissel N; Haferlach C; Loschi M; Raynaud S; Cluzeau T
Clin Lymphoma Myeloma Leuk; 2022 Mar; 22(3):e199-e205. PubMed ID: 34674982
[TBL] [Abstract] [Full Text] [Related]
13. Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia-A Nationwide Register-Based Cohort Study in Germany.
Dutzmann CM; Spix C; Popp I; Kaiser M; Erdmann F; Erlacher M; Dörk T; Schindler D; Kalb R; Kratz CP
J Clin Oncol; 2022 Jan; 40(1):32-39. PubMed ID: 34597127
[TBL] [Abstract] [Full Text] [Related]
14. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
[TBL] [Abstract] [Full Text] [Related]
15. Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia.
Kaburagi T; Yamato G; Shiba N; Yoshida K; Hara Y; Tabuchi K; Shiraishi Y; Ohki K; Sotomatsu M; Arakawa H; Matsuo H; Shimada A; Taki T; Kiyokawa N; Tomizawa D; Horibe K; Miyano S; Taga T; Adachi S; Ogawa S; Hayashi Y
Haematologica; 2022 Mar; 107(3):583-592. PubMed ID: 33730843
[TBL] [Abstract] [Full Text] [Related]
16. Deep Learning for Automatic Differential Diagnosis of Primary Central Nervous System lymphoma and Glioblastoma: Multi-Parametric Magnetic Resonance Imaging Based Convolutional Neural Network Model.
Xia W; Hu B; Li H; Shi W; Tang Y; Yu Y; Geng C; Wu Q; Yang L; Yu Z; Geng D; Li Y
J Magn Reson Imaging; 2021 Sep; 54(3):880-887. PubMed ID: 33694250
[TBL] [Abstract] [Full Text] [Related]
17. Crizotinib for recurring non-small-cell lung cancer with EML4-ALK fusion genes previously treated with alectinib: A phase II trial.
Harada D; Isozaki H; Kozuki T; Yokoyama T; Yoshioka H; Bessho A; Hosokawa S; Takata I; Takigawa N; Hotta K; Kiura K;
Thorac Cancer; 2021 Mar; 12(5):643-649. PubMed ID: 33470536
[TBL] [Abstract] [Full Text] [Related]
18. Trends in Cancer Incidence in US Adolescents and Young Adults, 1973-2015.
Scott AR; Stoltzfus KC; Tchelebi LT; Trifiletti DM; Lehrer EJ; Rao P; Bleyer A; Zaorsky NG
JAMA Netw Open; 2020 Dec; 3(12):e2027738. PubMed ID: 33258907
[TBL] [Abstract] [Full Text] [Related]
19. Management experience of advanced-stage mycosis fungoides/Sézary syndrome: a retrospective study from Spanish haematology referral units.
Novelli S; Martín A; Sánchez JJ; Espeso M; Mozos A; Briones J
Eur J Dermatol; 2020 Aug; 30(4):397-403. PubMed ID: 32815814
[TBL] [Abstract] [Full Text] [Related]
20. Real-world Experience of Imatinib in Pediatric Chronic Phase Chronic Myeloid Leukemia: A Single-center Experience From India.
Ganguly S; Pushpam D; Mian A; Chopra A; Gupta R; Bakhshi S
Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e437-e444. PubMed ID: 32247650
[TBL] [Abstract] [Full Text] [Related]
[Next]
